journal article·2010-08

Influence of polymer content in Ca-deficient hydroxyapatite–polycaprolactone nanocomposites on the formation of microvessel-like structures

S. Fuchs, X. Jiang, I. Gotman, C. Makarov, H. Schmidt, E.Y. Gutmanas, C.J. Kirkpatrick

Acta Biomaterialia· Volume 6· Issue 8
Publisher page

Abstract

Calcium phosphate (CaP) ceramics are widely used in bone tissue engineering due to their good osteoconductivity. The mechanical properties of CaP can be modified by the addition of small volume fractions of biodegradable polymers such as polycaprolactone (PCL). Nevertheless, it is also important to evaluate how the polymer content influences cell-material or cell-cell interactions because of potential consequences for bone regeneration and vascularization. In this study we assessed the general biocompatibilty of Ca-deficient hydroxyapatite (CDHA)-PCL disks containing nominally 11 and 24% polycaprolactone using human umbilical vein endothelial cells and human primary osteoblasts. Confocal microscopy showed that both CDHA-PCL variants supported the growth of both cell types. In terms of the endothelial cells grown on CDHA-PCL nanocomposites with 24% PCL, an increased expression of the endothelial marker vWF compared to CDHA-PCL with 11% PCL was observed in real-time polymerase chain reaction analysis. In addition to monocultures, co-cultures of outgrowth endothelial cells, derived from peripheral blood, and primary osteoblasts were assessed as an example of a more complex test system for bone regeneration and vascularization. Constructs based on CDHA with different PCL contents were investigated with regard to the formation of microvessel-like structures induced by the co-culture process using confocal microscopy and quantitative image analysis. Furthermore, the osteogenic differentiation of the co-culture was assessed. As a result, more pre-vascular structures were observed after 1 week on the CDHA-PCL disks with 24% PCL, whereas after 4 weeks of culture the extent of microvessel-like structure formation was slightly higher on the CDHA with 11% PCL. In contrast to this, variation of PCL content had no effect on the osteogenic differentiation in the co-culture.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Bone Tissue Engineering Materials · Orthopaedic implants and arthroplasty · Dental materials and restorations

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (48)

Show source-provided references
1. Engineering vascularized skeletal muscle tissue10.1038/nbt1109 ↗
2. Effect of HUVEC on human osteoprogenitor cell differentiation needs heterotypic gap junction communication10.1152/ajpcell.00310.2001 ↗
3. Human endothelial cells inhibit BMSC differentiation into mature osteoblasts in vitro by interfering with osterix expression10.1002/jcb.20818 ↗
4. Interaction between human umbilical vein endothelial cells and human osteoprogenitors triggers pleiotropic effect that may support osteoblastic function10.1016/j.bone.2008.01.025 ↗
5. Role of vascular endothelial growth factor in bone marrow stromal cell modulation of endothelial cells10.1089/107632703762687573 ↗
6. Healing of an ulnar defect using a proprietary TCP bone graft substitute, JAX, in association with autologous osteogenic cells and growth factors10.1016/j.bone.2006.11.004 ↗
7. Demineralized bone matrix and hydroxyapatite/tri-calcium phosphate mixture for bone healing in rats10.1007/s00264-006-0079-x ↗
8. Synthesis and application of hydroxyapatite/polylactide composite biomaterial10.1016/j.apsusc.2004.05.227 ↗
9. Development and properties of polycaprolactone/hydroxyapatite composite biomaterials10.1023/A:1022051326282 ↗
10. Composites of calcium phosphate and polymers as bone substitution materials10.1007/s00068-006-6044-y ↗
11. Tissue-like self-assembly in cocultures of endothelial cells and osteoblasts and the formation of microcapillary-like structures on three-dimensional porous biomaterials10.1016/j.biomaterials.2007.05.032 ↗
12. Crosstalk between osteoblasts and endothelial cells co-cultured on a polycaprolactone-starch scaffold and the in vitro development of vascularization10.1016/j.biomaterials.2009.05.004 ↗
13. Dynamic processes involved in the pre-vascularization of silk fibroin constructs for bone regeneration using outgrowth endothelial cells10.1016/j.biomaterials.2008.11.028 ↗
14. Diverse origin and function of cells with endothelial phenotype obtained from adult human blood10.1161/01.RES.0000105569.77539.21 ↗
15. Characterization of two types of endothelial progenitor cells and their different contributions to neovasculogenesis10.1161/01.ATV.0000114236.77009.06 ↗
16. Retention of a differentiated endothelial phenotype by outgrowth endothelial cells isolated from human peripheral blood and expanded in long-term cultures10.1007/s00441-006-0222-4 ↗
17. Microvessel-like structures from outgrowth endothelial cells from human peripheral blood in 2-dimensional and 3-dimensional co-cultures with osteoblastic lineage cells10.1089/ten.2007.0022 ↗
18. Contribution of outgrowth endothelial cells from human peripheral blood on in vivo vascularization of bone tissue engineered constructs based on starch polycaprolactone scaffolds10.1016/j.biomaterials.2008.09.058 ↗
19. Cold sintering under high pressure–mechanisms and application
20. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria10.1172/JCI107470 ↗
21. Bioengineered human bone tissue using autogenous osteoblasts cultured on different biomatrices10.1002/jbm.a.10594 ↗
22. Compressive properties and degradability of poly(ε-caprolatone)/hydroxyapatite composites under accelerated hydrolytic degradation10.1002/jbm.a.30996 ↗
23. Rasband WS. ImageJ, vol. 2008. Bethesda, Maryland, USA: US National Institutes of Health; 1997–2007.
24. Engineering vascularised tissues in vitro10.22203/eCM.v015a03 ↗
25. Cell culture models of higher complexity in tissue engineering and regenerative medicine10.1016/j.biomaterials.2007.08.012 ↗
26. Vascularization in bone tissue engineering: physiology, current strategies, major hurdles and future challenges10.1002/mabi.200900107 ↗
27. Cell-to-cell communication between osteogenic and endothelial lineages: implications for tissue engineering10.1016/j.tibtech.2009.07.001 ↗
28. Human primary endothelial cells stimulate human osteoprogenitor cell differentiation10.1159/000080342 ↗
29. Angiogenesis-like activity of endothelial cells co-cultured with VEGF-producing smooth muscle cells10.1089/ten.2006.12.ft-59 ↗
30. Endothelial cells assemble into a 3-dimensional prevascular network in a bone tissue engineering construct10.1089/ten.2006.12.2685 ↗
31. Co-culture of bone marrow fibroblasts and endothelial cells on modified polycaprolactone substrates for enhanced potentials in bone tissue engineering10.1089/ten.2006.12.ft-192 ↗
32. Improved tissue-engineered bone regeneration by endothelial cell mediated vascularization10.1016/j.biomaterials.2008.09.047 ↗
33. Influence of macroporous protein scaffolds on bone tissue engineering from bone marrow stem cells10.1016/j.biomaterials.2004.11.013 ↗
34. Sang-Soo K, Min Sun P, Seung-Woo C, Sun Woong K, Kang-Min A, Jong-Ho L, et al. Enhanced bone formation by marrow-derived endothelial and osteogenic cell transplantation. J Biomed Mater Res Part A 2009;9999:NA.
35. Simultaneous cultivation of human endothelial like differentiated precursor cells and human marrow stromal cells on beta-Tricalciumphosphate10.1089/ten.tec.2008.0385 ↗
36. Dohle E, Fuchs S, Kolbe M, Hofmann S, Schmidt H, Kirkpatrick CJ. Sonic Hedgehog promotes angiogenesis and osteogenesis in a co-culture system consisting of primary osteoblasts and outgrowth endothelial cells. Tissue Eng C 2010; in press.10.1089/ten.tea.2009.0493 ↗
37. Endothelial cadherins and tumor angiogenesis10.1016/j.yexcr.2005.09.019 ↗
38. Engineering bone-like tissue in vitro using human bone marrow stem cells and silk scaffolds10.1002/jbm.a.30117 ↗
39. Progressive development of the rat osteoblast phenotype in vitro: reciprocal relationships in expression of genes associated with osteoblast proliferation and differentiation during formation of the bone extracellular matrix10.1002/jcp.1041430304 ↗
40. Expression of bone matrix proteins mRNA during distraction osteogenesis10.1359/jbmr.1998.13.8.1221 ↗
41. Alterations in the expression of osteonectin, osteopontin and osteocalcin mRNAs during the development of skeletal tissues in vivo10.1016/S0169-6009(08)80056-6 ↗
42. Requisite roles of Runx-2 and Cbfb in skeletal development
43. Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation10.1016/S0092-8674(00)80257-3 ↗
44. Biocompatibility and osteogenicity of degradable Ca-deficient hydroxyapatite scaffolds from calcium phosphate cement for bone tissue engineering10.1016/j.actbio.2008.07.018 ↗
45. Ectopic bone formation associated with mesenchymal stem cells in a resorbable calcium deficient hydroxyapatite carrier10.1016/j.biomaterials.2005.03.001 ↗
46. Comparison of human bone marrow stromal cells seeded on calcium-deficient hydroxyapatite, [beta]-tricalcium phosphate and demineralized bone matrix10.1016/S0142-9612(03)00062-0 ↗
47. Apatite-mineralized polycaprolactone nanofibrous web as a bone tissue regeneration substrate10.1002/jbm.a.31709 ↗
48. Biocompatibility of poly-epsilon-caprolactone–hydroxyapatite composite on mouse bone marrow-derived osteoblasts and endothelial cells10.1186/1749-799X-4-5 ↗